Inventor · disambiguated record
Hubertus Hochrein
Also filed as: HOCHREIN HUBERTUS
16 granted patents·4 pending applications·27 citations·filing 2007–2023
89Inventor score
Top patents by PatentIndex Score
20 records- 0186US10973892B2Methods and compositions for enhancing vaccine immune responsesBAVARIAN NORDIC AS·Filed 2013·Granted Apr 13, 2021·5 cites·15 claims
- 0282US8053234B2Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)BAVARIAN NORDIC AS·Filed 2007·Granted Nov 8, 2011·4 cites·8 claims
- 0381US8268327B2Immediate protection against pathogens via MVAHOCHREIN HUBERTUS·Filed 2008·Granted Sep 18, 2012·5 cites·12 claims
- 0480US8883168B2Modulation of immune responses by the poxviral K4 proteinHAUSMANN JÜRGEN·Filed 2011·Granted Nov 11, 2014·4 cites·28 claims
- 0580US8445275B2Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)HOCHREIN HUBERTUS·Filed 2008·Granted May 21, 2013·2 cites·21 claims
- 0679US8268328B2Immediate protection against pathogens via MVAHOCHREIN HUBERTUS·Filed 2008·Granted Sep 18, 2012·4 cites·18 claims
- 0771US9556439B2Agonists and antagonists of toll-like receptor (TLR) 13BAVARIAN NORDIC AS·Filed 2013·Granted Jan 31, 2017·1 cites·6 claims
- 0871US9090897B2Production of IFN-lambda by conventional dendritic cellsHOCHREIN HUBERTUS·Filed 2010·Granted Jul 28, 2015·2 cites·19 claims
- 0967US11723964B2Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVABAVARIAN NORDIC AS·Filed 2022·Granted Aug 15, 2023·0 cites·9 claims
- 1062US2025002606A1Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVABAVARIAN NORDIC AS·Filed 2023·Application pending·0 cites
- 1161US2021299236A1Methods and Compositions for Enhancing Vaccine Immune ResponsesBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 1259US11273211B2Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibodyBAVARIAN NORDIC AS·Filed 2018·Granted Mar 15, 2022·0 cites·9 claims
- 1359US8354275B2Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)BAVARIAN NORDIC AS·Filed 2011·Granted Jan 15, 2013·0 cites·19 claims
- 1459US2009148405A1Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) receptor ligandsHOCHREIN HUBERTUS·Filed 2008·Application pending·0 cites
- 1558US11338030B2Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogensBAVARIAN NORDIC AS·Filed 2020·Granted May 24, 2022·0 cites·12 claims
- 1656US8961998B2Immediate protection against pathogens via MVAHOCHREIN HUBERTUS·Filed 2012·Granted Feb 24, 2015·0 cites·18 claims
- 1746US10576141B2Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of useBAVARIAN NORDIC AS·Filed 2015·Granted Mar 3, 2020·0 cites·12 claims
- 1840US2017137820A1Agonists and antagonists of toll-like receptor (tlr) 13BAVARIAN NORDIC AS·Filed 2017·Application pending·0 cites
- 1932US10512684B2Methods and compositions for intra-nasal immunization with recombinant MVA encoding flagellinBAVARIAN NORDIC AS·Filed 2015·Granted Dec 24, 2019·0 cites·27 claims
- 2031US9149515B2Interferon-alpha-producing bone marrow dendritic cellsO'KEEFFE MEREDITH·Filed 2011·Granted Oct 6, 2015·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Hubertus Hochrein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →